Skip to main content
. Author manuscript; available in PMC: 2011 Mar 25.
Published in final edited form as: Eur Heart J. 2009 Dec 21;31(13):1655–1662. doi: 10.1093/eurheartj/ehp555

Fig. 3.

Fig. 3

Results of the in situ rabbit heart experiments with infarct size assessment after 4 h of reperfusion (left panel) or 72 h (right panel). Canrenoate was applied as a 1 mg/kg bolus 5 min prior to reperfusion identical to the mouse experiments and clearly reduced infarct size presented at a percentage of the risk zone. *p<0.05 vs. control